Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct-Nov;87(4-5):127-34.
doi: 10.1016/j.plefa.2012.08.003. Epub 2012 Sep 10.

Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma

Affiliations

Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma

A M Gil-Villa et al. Prostaglandins Leukot Essent Fatty Acids. 2012 Oct-Nov.

Abstract

Introduction: Preeclampsia is a disorder of pregnancy, characterized by hypertension and proteinuria after 20 weeks of gestation. Here, we evaluated the role of aspirin triggered-lipoxin A(4) (ATL, 15-epi-LXA(4)) on the modulation of the adhesion of human polymorphonuclear neutrophils (PMN) to endothelial cells initiated by preeclamptic plasma.

Materials and methods: Plasma from preeclamptic, normotensive pregnant, and non-pregnant women were analyzed for factors involved in regulating angiogenesis, inflammation and lipid peroxidation. Plasma from preeclamptic women was added to human umbilical vein endothelial cells, and the adhesion of PMN (incubated with or without ATL) to cells was evaluated.

Results: Preeclampsia was associated with some augmented anti-angiogenic, oxidative and pro-inflammatory markers, as well as increasing human PMN-endothelial cell adhesion. This cell adhesion was reduced when human PMN were incubated with ATL prior to addition to endothelial monolayers.

Discussions and conclusions: Our results are the starting point for further research on the efficacy and rational use of aspirin in preeclampsia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosure

C.N.S. is the inventor on patents for lipoxin analogs (aspirin triggered-lipoxin A4) that are assigned to Brigham and Women’s Hospital and licensed for clinical development. CNS’ interests were reviewed and are managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.

Figures

Figure 1
Figure 1. Plasma levels of pro-angiogenic and pro-inflammatory mediators are elevated in preeclamptic women
Plasma was obtained from non-pregnant (n=11), normotensive pregnant (n=15) and preeclamptic pregnant (n=14) women and inflammatory markers and angiogenic factors were analyzed by Luminex. Data were normalized by quantification of plasma protein. *P<0.05, **P<0.01,***P<0.001.
Figure 2
Figure 2. Lipid mediator levels are modulated in women with preeclampsia
Plasma was obtained from non-pregnant (n=13), normotensive pregnant (n=17) and preeclampitc pregnant (n=14) women and analyzed by enzyme–linked immunosorbent assay. *P<0.05, **P<0.01,***P<0.001.
Figure 3
Figure 3. Systemic oxidative stress is elevated in preeclamptic patients
Lipid peroxidation levels as measured by TBARS (A), and 8-isoprostane (B) were measured in plasma of women with preeclampsia (n=12) as compared with normotensive pregnant women (n=15) and non-pregnant women (n=8). *P<0.05, **P<0.01,***P<0.001.
Figure 4
Figure 4. Aspirin-triggered lipoxin (ATL) reduces leukocyte-endothelial interactions initiated by preeclamptic plasma, 8-isoprostane and TBARS: Endothelial and leukocyte directed actions
HUVEC cells were stimulated overnight with IL-1β (positive control, 10 ng/mL), plasma from normotensive pregnant women (n=4) or preeclamptic women (n=8). Then, PMN labeled with CFDA-SE were added to pre-stimulated HUVEC cells, and cell adhesion was assessed after 15min as described in methods (A). On the other hand, HUVEC were stimulated overnight with 8-isoprostane (0.1–1000 nM) (C) and TBARS (1–100.000 nM) (E). Human PMN were incubated with ATL (10nM; 15min) prior to addition to stimulated HUVEC monolayers with plasma, 8-isoprostane and TBARS, respectively (B,D,F). Results are mean ± s.e.m *P<0.05, **P<0.01,***P<0.001
Figure 5
Figure 5. Isoprostane and TBARS stimulate PMN adhesion to HUVEC
Human PMN were stimulated with Leukotriene B4 (positive control, 10 nM; 30min), 8-isoprostane (1–1000 nM; 30min) or TBARS (1–1000 nM; 30min) and adhesion to non-stimulated HUVEC was assessed after 15min (A). Human PMN were incubated with ATL (10nM; 15min) prior to addition to stimulated HUVEC monolayers (B). *P<0.05, **P<0.01,***P<0.001
Figure 6
Figure 6. Proposed function of 15-epi-Lipoxin A4 (ATL) on maternal vascular endothelium response to placenta derived substances
In pregnancy placenta generated pro-inflammatory cytokines (PIC), reactive oxidative stress molecules (ROS) and syncytiotrophoblast microfragments gain access to the maternal systemic circulation. These molecules stimulate inflammation of the maternal vascular endothelium, the production of ROS, PIC, and vasoactive prostaglandins (PG) leading to endothelial activation, polymorphonuclear neutrophil (PMN) adhesion and transmigration and vascular leakage. This sets the stage for a feed forward cyclic process in which mediators from the endothelium stimulate the placenta to produce ROS, PIC and other inflammatory mediators. In preeclampsia this theoretical scenario is increased as compared to normal pregnancies leading to adverse clinical manifestations. ATL may be beneficial in the treatment of preeclampsia by decreasing the oxidative and pro-inflammatory responses and their downstream consequences.

Similar articles

Cited by

References

    1. Meis PJ, Goldenberg RL, Mercer BM, et al. The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol. 1998;178:562–7. - PubMed
    1. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36:56–9. - PubMed
    1. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80–6. - PubMed
    1. Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Pregnancy. 2002;21:205–23. - PubMed
    1. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21:597–602. - PubMed

Publication types